Share This Page
Drug Price Trends for TRIPHROCAPS SOFTGEL
✉ Email this page to a colleague
Average Pharmacy Cost for TRIPHROCAPS SOFTGEL
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TRIPHROCAPS SOFTGEL | 13811-0525-01 | 0.13768 | EACH | 2025-03-19 |
| TRIPHROCAPS SOFTGEL | 13811-0525-01 | 0.13464 | EACH | 2025-02-19 |
| TRIPHROCAPS SOFTGEL | 13811-0525-01 | 0.12587 | EACH | 2025-01-22 |
| TRIPHROCAPS SOFTGEL | 13811-0525-01 | 0.12892 | EACH | 2024-12-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for TRIPHROCAPS SOFTGEL
Market Overview of Softgel Capsules
The global softgel capsules market is experiencing significant growth, driven by several key factors. As of 2022, the market size was valued at USD 7.67 billion and is anticipated to grow at a CAGR of 6.9% from 2023 to 2030[1].
TRIPHROCAPS SOFTGEL: Product Details
- Brand Name: TRIPHROCAPS SOFTGEL
- Generic Name: B complex w-C no.20/folic acid
- Manufacturer: TRIGEN LABORATORIES
- NDC: 13811052501
- Package Size: 100EA
- Prescription/OTC: Over the counter (OTC)[2].
Market Segmentation and Regional Analysis
The softgel capsules market is segmented into various regions, with North America currently holding the largest revenue share. In 2022, North America accounted for 42.3% of the global market, driven by advanced production technology, the presence of major players, and significant R&D investments[1].
However, the Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. This rapid growth is attributed to the large presence of generic medicine manufacturers in countries like China and India, increasing demand for cost-efficient therapeutics, and the expansion of contract manufacturing organizations in the region[1][3].
Growth Drivers for Softgel Capsules
Several factors are driving the growth of the softgel capsules market:
- Clinical Trials and Research: The increasing number of clinical trials evaluating the effectiveness of softgel capsules in treating various ailments is a significant growth driver. For instance, clinical studies on the safety and tolerability of soft gelatin capsules in patients with advanced biliary tract cancer are supporting market growth[4].
- Technological Advancements: Continuous advancements in manufacturing technology have led to the development of softgel capsules with controlled drug release, tamper-evident properties, and improved bioavailability. These advancements enhance the attractiveness and functionality of softgel capsules[1].
- Consumer Preferences: Health-conscious consumers prefer softgel capsules due to their ease of swallowing, effective masking of odor and taste, and excellent atmospheric stability[1].
Price Projections and Market Trends
The global softgel capsules market is projected to grow significantly over the next decade. Here are some key projections:
- Global Market Size: Expected to grow from USD 7.07 billion in 2023 to USD 11.84 billion by 2032, at a CAGR of 5.9%[4].
- Regional Growth: North America is anticipated to hold the largest share of the global market, while the Asia Pacific region is expected to grow at the fastest CAGR[3][4].
TRIPHROCAPS SOFTGEL Pricing
As an OTC product, the pricing of TRIPHROCAPS SOFTGEL is relatively stable and competitive. Here are some key pricing details:
- Price: The current price for TRIPHROCAPS SOFTGEL is approximately $0.54882 per unit, as per the vendor drug program[2].
Competitive Analysis
The softgel capsules market is highly competitive, with several major players investing heavily in R&D to develop novel softgel dosage formulations. Companies like International Flavors & Fragrances (IFF) are introducing innovative products, such as pectin-based technologies for vegan softgels, to expand their market share[4].
Challenges and Opportunities
While the market is growing, there are challenges such as the loss of patent exclusivity for pharmaceutical companies, which can lead to a decline in revenues. However, opportunities abound in regions like the Asia Pacific, where the expansion of the pharmaceutical market and the growth of contract manufacturing organizations are driving market growth[4].
Key Takeaways
- The global softgel capsules market is growing rapidly, driven by technological advancements, clinical trials, and consumer preferences.
- North America currently dominates the market, but the Asia Pacific region is expected to grow at the fastest CAGR.
- TRIPHROCAPS SOFTGEL, as an OTC product, benefits from the overall growth trends in the softgel capsules market.
- Pricing for TRIPHROCAPS SOFTGEL is competitive and stable, reflecting the broader market dynamics.
Frequently Asked Questions (FAQs)
Q: What is the current market size of the global softgel capsules market? A: The global softgel capsules market size was valued at USD 7.67 billion in 2022[1].
Q: What is the projected CAGR for the global softgel capsules market from 2023 to 2030? A: The market is anticipated to grow at a CAGR of 6.9% from 2023 to 2030[1].
Q: Which region is expected to grow the fastest in the softgel capsules market? A: The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period[1][3].
Q: What are the key drivers of the softgel capsules market growth? A: Key drivers include clinical trials, technological advancements, and consumer preferences for ease of swallowing and improved bioavailability[1][4].
Q: What is the current price of TRIPHROCAPS SOFTGEL? A: The current price for TRIPHROCAPS SOFTGEL is approximately $0.54882 per unit[2].
Sources:
- Grand View Research - Softgel Capsules Market Size, Share & Growth Report, 2030
- TxVendordrug - TRIPHROCAPS SOFTGEL - Vendor Drug Program
- Spherical Insights - Softgel Capsule Market Growth, Analysis, Trend, forecasts to 2033
- Fortune Business Insights - Softgel Capsules Market Size, Share | Growth Analysis [2032]
More… ↓
